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The sperm protein fertilin (also known as PH-30) is a candidate for mediating the interactions between sperm and egg
plasma membranes. Fertilin is a heterodimer. The b subunit, which has a region with homology to the family of integrin
ligands known as disintegrins, has been hypothesized to be involved in the binding of sperm to the egg surface. To investigate
this hypothesis and determine what role fertilin b plays in fertilization, we have expressed the putative extracellular domain
of mouse fertilin b in bacteria as a fusion protein with maltose-binding protein (hereafter referred to as recombinant fertilin
b-EC) and used two assays to characterize its binding to mouse eggs. Immunocytochemistry was used to examine the
localization of recombinant fertilin b-EC binding. A luminometric assay was also developed to quantify levels of binding
of recombinant fertilin b-EC to single eggs. We ®nd that recombinant fertilin b-EC binds to the region of the plasma
membrane of the egg to which sperm bind, thus providing the ®rst direct evidence that fertilin b has adhesive properties.
Peptides corresponding to the disintegrin domain of fertilin b reduce its binding to eggs, suggesting that this domain is at
least partially involved in the recognition of fertilin b by binding sites on the egg. Treatment of zona pellucida-free eggs
with chymotrypsin reduces the ability of the eggs to support the binding of recombinant fertilin b-EC, implicating an egg
surface protein as a binding site for recombinant fertilin b-EC. Binding of recombinant fertilin b-EC to eggs is also reduced
in the absence of divalent cations and is supported by 2.0 mM Ca2/, Mg2/, or Mn2/. Furthermore, eggs incubated in
recombinant fertilin b-EC prior to in vitro fertilization show reduced levels of sperm binding. Finally, we have examined
the possible role of integrins on eggs as receptors for fertilin b, since an anti-a6 integrin subunit monoclonal antibody,
GoH3, has been shown to inhibit sperm binding (E. A. C. Almeida et al. (1995) Cell 81, 1095±1104). We ®nd that: (a) an
increased amount of GoH3 epitope on the egg surface does not correlate with an increased ability of the eggs to bind sperm
or recombinant fertilin b-EC; (b) the GoH3 antibody has virtually no inhibitory effect on recombinant fertilin b-EC binding;
and (c) recombinant fertilin b-EC binding is reduced in the presence of anti-b1 integrin antibodies. These results suggest
that a b1-containing integrin participates in the binding of recombinant fertilin b-EC to mouse eggs. q 1997 Academic Press
INTRODUCTION Anderson et al., 1989; FeÂnichel et al., 1990), complement
component C3b associated with the equatorial segment of
acrosome-reacted sperm (Anderson et al., 1993), comple-The molecular basis of interactions between sperm and
ment component C1q and its receptor (Fusi et al., 1991),egg plasma membranes is poorly understood. Speci®c do-
extracellular matrix proteins (Fusi and Bronson, 1992; Fusimains on the sperm membrane (equatorial segment and pos-
et al., 1994; Hoshi et al., 1994), and novel molecules identi-terior head) and egg membrane (microvillar region) are in-
®ed by anti-sperm antibodies that inhibit sperm±egg bind-volved in this process (Yanagimachi, 1994), and several can-
ing and/or fusion (CuasnicuÂ et al., 1984; Saling et al., 1985;didate molecules on both gametes' surfaces have been
Primakoff et al., 1987; Okabe et al., 1988, 1990;proposed to participate in the binding and/or fusion of the
GarcõB a-Framis et al., 1994; Allen and Green, 1995). Like-gamete membranes. Sperm candidates include a galactosyl-
wise, egg candidates include a trypsin- and chymotrypsin-transferase on the equatorial segment (Lopez and Shur,
1987), CD46 (also known as membrane cofactor protein; sensitive protein of Mr  94,000 (Kellom et al., 1992), the
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C1q receptor (Fusi et al., 1991), integrins that recognize remains unclear. It has been hypothesized that fertilin b,
the Arg±Gly±Asp (RGD) tripeptide sequence (Bronson and via its disintegrin domain, mediates sperm±egg membrane
Fusi, 1990; Bronson et al., 1995), the C3b receptor integrin binding, and that fertilin a, via its fusion peptide, mediates
aMb2 (Anderson et al., 1993), the laminin receptor integrin sperm±egg fusion (Blobel et al., 1992; Myles, 1993). How-
a6b1 (Almeida et al., 1995), and antigens of antibodies to ever, to date, there has been no direct evidence to support
egg surfaces (Jin et al., 1996). this hypothesis. Indirect evidence for the role of fertilin b in
The sperm antigen fertilin (formerly known as PH-30) is cell adhesion comes from the demonstration that synthetic
one of the most promising candidates to mediate gamete peptides corresponding to the disintegrin domain inhibit
interactions for the following reasons. First, it is localized sperm±egg membrane interactions (Myles et al., 1994; Al-
to the posterior head of sperm, a region that is involved in meida et al., 1995; Evans et al., 1995b). While some hetero-
binding to and fusion with the egg membrane (Primakoff et dimeric proteins are functional in the dimerized form (e.g.,
al., 1987). Second, the monoclonal antibody PH-30, which integrins; Buck et al., 1986), there are data which suggest
recognizes fertilin, inhibits sperm±egg fusion (Primakoff et that the fertilin b subunit, in the absence of the a subunit,
al., 1987). Third, fertilin is a heterodimer that is proteolyti- is functional (Myles et al., 1994; Almeida et al., 1995; Evans
cally processed from a full-length precursor form to a ma- et al., 1995b). Furthermore, since the fertilin b and a sub-
ture form at a time during epididymal transit that corre- units have been hypothesized to have different roles in fer-
sponds to the acquisition of fertilization competence (Blobel tilization (binding and fusion, respectively), it is worthwhile
et al., 1990). Finally, cDNA cloning and sequence analysis to examine each subunit individually. In the present study,
reveals that the fertilin a subunit contains a region with we have expressed the extracellular domain of the predicted
homology to viral fusion peptides, suggestive of a role for mature, proteolytically processed b subunit in bacteria as
fertilin a in sperm±egg fusion. Moreover, the fertilin b sub- a fusion protein with maltose-binding protein (MBP); here-
unit contains a domain with homology to a family of inte- after, this fusion protein will be referred to as recombinant
grin ligands known as disintegrins, suggesting a cell adhe- fertilin b-EC. We demonstrate that recombinant fertilin b-
sive function for fertilin b (Blobel et al., 1992). EC binds to eggs with properties similar to those of sperm
Disintegrins, originally identi®ed in snake venom pro- with respect to localization, inhibition of binding by syn-
teins (Gould et al., 1990), interact with integrins through a thetic peptides corresponding to the disintegrin domain, re-
domain containing tripeptide sequences that mimic the duced binding to chymotrypsin-treated eggs, and divalent
Arg±Gly±Asp (RGD) tripeptide recognition sequence of cation dependence of binding. Moreover, recombinant fer-
various integrin ligands. A new family of cellular disinte- tilin b-EC inhibits sperm binding to eggs. These data are
grin-related molecules comprise the ADAM (A Disintegrin
the ®rst direct evidence that implicate fertilin b on sperm
and Metalloprotease domain) or MDC (Metalloprotease-
as a cell adhesion molecule involved in mediating the bind-Disintegrin-Cysteine rich) family (Wolfsberg et al., 1995a).
ing of sperm to the egg membrane.These proteins include the fertilins [identi®ed in six species
It has also been postulated that fertilin b, via its disinte-(Wolfsberg et al., 1993; Evans et al., 1995b; Perry et al.,
grin domain, interacts with an integrin or integrin-like mol-1995; Wolfsberg et al., 1995b; Hardy and Holland, 1996;
ecule on the plasma membrane of the egg (Blobel et al.,Ramarao et al., 1996; Vidaeus et al., 1997)], the meltrins
1992; Myles, 1993). This is based on the ®nding that snake(Yagami-Hiromasa et al., 1995), cyritestin (Barker et al.,
venom disintegrins interact with integrins, heterodimeric1994; Heinlein et al., 1994; Wolfsberg et al., 1995b), MDC9
membrane proteins of a and b subunits that mediate cell±(Weskamp et al., 1996), metargidin (KraÈtzschmar et al.,
matrix and cell±cell interactions (Gould et al., 1990; Haas1996), and the Drosophila Kuzbanian (Rooke et al., 1996).
and Plow, 1994; Loftus et al., 1994). In agreement with thisAll of these molecules have similar domain structures, in-
hypothesis, the a6b1 integrin is implicated in mouse spermcluding a signal sequence, a prodomain, a metalloprotease
binding to mouse eggs (Almeida et al., 1995), and aMb2 anddomain (although not all have a characteristic enzyme ac-
RGD-binding integrins are implicated human sperm inter-tive site; Wolfsberg et al., 1995a), a disintegrin domain, a
actions with hamster eggs (Bronson and Fusi, 1990; Ander-cysteine-rich domain, an EGF-like repeat, a putative trans-
son et al., 1993). However, the only evidence of an interac-membrane domain, and a cytoplasmic tail (see Fig. 1A).
tion between fertilin b and an integrin is indirect. SyntheticSeveral of these proteins appear to be proteolytically pro-
peptides corresponding to the disintegrin domain of fertilincessed from precursor to mature forms (Blobel et al., 1990;
b have been reported to inhibit the binding of GoH3, anLinder et al., 1995; Yagami-Hiromasa et al., 1995). The pro-
anti-a6 integrin monoclonal antibody, suggesting that theteolytic cleavage site in fertilin b lies between the metallo-
peptide and the GoH3 antibody bind to the same sites onprotease and the disintegrin domains (Blobel et al., 1992);
the egg surface (Almeida et al., 1995). In this study we alsothus, the mature form of fertilin b present on sperm con-
show that the binding of recombinant fertilin b-EC to eggstains in its extracellular domain only the disintegrin do-
is inhibited with an anti-b1 integrin antibody, suggestingmain, the cysteine-rich domain, and the EGF-like repeat
that sperm fertilin b interacts with an egg b1 integrin. How-(see Fig. 1A).
ever, the function-blocking anti-a6 antibody GoH3 had noWhile many members of the ADAM molecular family
have been identi®ed, the function(s) for several of them effect on the binding of recombinant fertilin b-EC.
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cin). The protein was then concentrated to 1 mg/ml; protein con-MATERIALS AND METHODS
centration was determined using a BCA Microassay kit (Pierce;
Rockford, IL). Each batch of recombinant fertilin b-EC prepared by
Production of Recombinant Fertilin b-EC this protocol was checked using three criteria: (1) detection of an
electrophoretic shift by SDS±PAGE under reducing versus nonre-
The region encoding the extracellular domain of mouse fertilin ducing conditions; (2) binding to ZP-free eggs, and (3) inhibiting
b (nt 1165-2058, counting the A of the ATG start codon as nt 1) sperm binding in in vitro fertilization. For all series of experiments,
was prepared by PCR ampli®cation from mouse fertilin b plasmid at least two different batches of recombinant fertilin b-EC were
DNA (Evans et al., 1995b) with a 5* primer corresponding to nt used.
1165±1178 of Accession No. U16242 (Evans et al., 1995b) and engi-
neered with a BamHI restriction site (CAGGATCCATGGCGG-
TCTGTGG) and a 3* primer corresponding to nt 2045±2058 engi- Egg Collection and Zona Pellucida Removal
neered with a stop codon and a SalI restriction site (TTTTGTCGA-
Eggs were obtained from superovulated CF-1 mice (Harlan, India-CTTACCGTGGAGACTTGG); ampli®cation was performed in a
napolis, IN) and cumulus cells were dispersed as previously de-PEC 2400 thermocycler (Perkin±Elmer, Norwalk, CT). For the ex-
scribed (Evans et al., 1995b). Unless otherwise indicated, the zonaperiments shown in Fig. 9, recombinant fertilin b-EC lacking the
pellucida (ZP) were removed by a very brief incubation (£15 sec)disintegrin domain was used; the DNA encoding this protein was
in Acidic MEM-compatible buffer (Acidic MEMCO, 10 mM Hepes,prepared by PCR ampli®cation using the 5* primer corresponding
1 mM NaH2PO4, 0.8 mM MgSO4, 5.4 mM KCl, 116.4 mM NaCl,to nt 1438±1454 of Accession No. U16242 and engineered with a
®nal pH 1.5) and then allowed to recover for 60 min (Evans et al.,BamHI restriction site (CAGGATCCTGTGACAATCGCAAGTG)
1995a); eggs treated in this way will be referred to as ``acid-treated.''and the 3* primer shown above. The PCR products were then di-
The enzymatic-mechanical method of ZP removal described bygested with BamHI and SalI and cloned into pMAL-p2 (New En-
Boldt and Wolf (1986) and Almeida et al. (1995) was also used; thisgland Biolabs; Beverly, MA). The resulting plasmids encoding re-
method is abbreviated ``CTM'' for chymotrypsin-mechanical. ZP-combinant fertilin b-EC (pMAL-b.10) (Fig. 1B) and recombinant
free eggs were then washed in Whitten's medium (Whitten, 1971)fertilin b-EC lacking the disintegrin domain (pMAL-bCE.2) were
containing 15 mg/ml BSA and allowed to recover for at least 60sequenced to verify that the insert was in frame and that the coding
min in Whitten's medium containing 22 mM bicarbonate and 15sequence was correct. Restriction enzyme digests, ligations, trans-
mg/ml BSA in a gassed (5% CO2, 5% O2, 90% N2) chamber.formations, and selections of transformants were performed ac-
cording to standard protocols (Sambrook et al., 1989).
Bacterial protein products and puri®ed protein were analyzed by
Chymotrypsin Treatment of Eggs12.5% SDS±PAGE (Laemmli, 1970) under reducing (sample buffer
containing 20 mM DTT) or nonreducing conditions. Silver staining ZP-free eggs were treated with chymotrypsin essentially as pre-
of SDS±PAGE gels was performed as described previously (Blum viously described (Boldt et al., 1988). ZP-free eggs were washed
et al., 1987). For immunoblot analysis, proteins were electrophoret- through six drops (100±200 ml each) of Whitten's medium con-
ically transferred to an Immobilon P membrane (Millipore, Bedford, taining 0.01% polyvinyl alcohol (PVA; cold water soluble, 30,000±
MA), probed with an anti-MBP antibody (1:10,000; New England 70,000 kDa; Sigma, St. Louis, MO), and then incubated in 1 mg/ml
Biolabs) followed by a horseradish peroxidase (HRP)-conjugated a-chymotrypsin (type II from bovine pancreas, Sigma) in Whitten's
goat anti-rabbit IgG secondary antibody (1:10,000; Jackson Immu- medium containing PVA for 20 min at 377C in a gassed (5% CO2,
noresearch, West Grove, PA), and then detected with an enhanced 5% O2, 90% N2) chamber. Following chymotrypsin treatment, eggs
chemiluminescent (ECL) HRP substrate according to the manufac- were washed through six drops of Whitten's medium containing
turer's instructions (Amersham, Arlington Heights, IL). 15 mg/ml BSA and allowed to recover for 45±60 min.
pMAL-b.10-carrying DH5a Escherichia coli were determined to
express a protein of the predicted size (Mr 78,000, reducing condi-
tions) that cross-reacted with anti-MBP antibodies on Western blots Immunocytochemical Detection of Recombinant
in response to induction with isopropylthiogalactoside (IPTG; Fertilin b-EC Binding to Eggs
Sigma, St. Louis, MO) but not in uninduced or untransformed bac-
teria (data not shown). For large-scale production of recombinant ZP-free eggs were incubated for 1 hr in varying concentrations
of recombinant fertilin b-EC or MBP (0.5 mg/ml unless otherwisefertilin b-EC or MBP, a 1-liter culture of pMAL-b.10- or pMAL-p2-
carrying DH5a E. coli was induced with 0.1 mM IPTG at 307C for noted) in Whitten's medium containing 22 mM sodium bicarbonate
and 15 mg/ml fatty acid-poor BSA in a gassed (5% CO2, 5% O2,2 hr. Proteins from the bacterial periplasmic space were isolated
by cold osmotic shock according to the manufacturer's instructions 90% N2) chamber. Unless otherwise noted, Whitten's medium was
supplemented so that the ®nal concentrations of Ca2/ and Mg2/(New England Biolabs). Recombinant fertilin b-EC (or MBP) was
puri®ed from the cold osmotic shock ¯uid by af®nity chromatogra- were 2.4 and 1.2 mM, respectively, and the ®nal glucose concentra-
tion was 5.5 mM; the ®nal concentration of BSA was 15 mg/ml. Aphy on amylose resin (New England Biolabs). Protein-containing
fractions were pooled and dialyzed against PBS, and then concen- CAQDEC peptide, corresponding to the disintegrin domain of
mouse fertilin b, and a scrambled control peptide, CDEQAC, weretrated to 1 mg/ml. On average, a 1-liter culture yielded 1±4 mg
of recombinant fertilin b-EC. To prepare protein for egg-binding synthesized by Quality Controlled Biochemicals, and characterized
for their ability to inhibit sperm binding in a concentration-depen-studies, recombinant fertilin b-EC was reduced by treating with
20 mM DTT for 30±60 min at room temperature. The sample was dent manner (Evans et al., 1995b). Studies of recombinant fertilin
b-EC binding in the presence of these peptides or divalent cationsthen dialyzed extensively against a Hepes-buffered Whitten's me-
dium compatible dialysis buffer (WHITCO; 109.5 mM NaCl, 4.7 were performed using the culturing conditions described previously
(Evans et al., 1995b).mM KCl, 1.2 mM KH2PO4, 0.23 mM sodium pyruvate, 4.8 mM
sodium lactate, 7 mM NaHCO3, 15 mM Hepes, 0.1 mg/ml gentami- Following incubation in recombinant fertilin b-EC, the eggs were
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washed through two 200-ml drops of medium and then ®xed in search Diagnostics, Flanders, NJ), P4C10, anti-human b1 (Gibco-
freshly prepared 4.0% paraformaldehyde in PBS for 20±30 min. All BRL; Gaithersburg, MD), and several anti-human av polyclonal an-
steps were performed at room temperature in a humidi®ed chamber tibodies (from Jeffrey W. Smith, Scripps Research Institute, and
as described previously (Evans et al., 1995a), using an anti-MBP from Gibco-BRL)] showed negligible cross-reactivity with epitopes
antibody (New England Biolabs; diluted 1:300), followed by a goat on the surfaces of acid-treated and CTM-treated eggs and did not
anti-rabbit IgG Texas red-conjugated secondary antibody (Jackson inhibit sperm binding or recombinant fertilin b-EC binding (data
Immunoresearch) diluted 1:500 with 2 mg/ml DAPI (4*,6-diamidino- not shown).
2-phenylindole; Sigma). For studies of in vitro maturation of GV- Anti-integrin IgGs and control nonimmune rat and rabbit IgGs
intact oocytes, FITC-conjugated phalloidin (®nal concentration 50 (Jackson Immunoresearch) were puri®ed by chromatography on
mg/ml; Sigma) was included with the secondary antibody. The eggs Protein G beads (Gibco-BRL). Antibodies were dialyzed against
were mounted in VectaShield mounting medium (Vector Labs, Bur- WHITCO, and then concentrated to ⁄5 mg/ml. For detection of
lingame, CA), and were viewed by epi¯uorescence. antibody binding, live ZP-free eggs were incubated in antibody (di-
luted to 0.5 mg/ml in Whitten's medium containing 15 mg/ml fatty
acid-poor BSA) for 60 min at 377C in a gassed (5% CO2, 5% O2,
Luminometric Detection of Recombinant Fertilin 90% N2) chamber. The eggs were then washed twice and ®xed in
freshly prepared 4.0% paraformaldehyde in PBS for 20±30 min atb-EC Binding to Eggs
room temperature. Bound antibody was detected by both immuno-
Following incubation of eggs with recombinant fertilin b-EC, cytochemical and luminometric methods, using ¯uorophore-conju-
the eggs were washed as described above and ®xed in freshly pre- gated goat-anti rat or rabbit IgG antibodies (diluted 1:500) or AP-
pared 4% paraformaldehyde in PBS for 30 min. Fixed eggs were conjugated goat-anti rat or rabbit IgG antibodies (diluted 1:10,000),
then washed twice in PBS and then blocked in alkaline phosphatase respectively.
(AP)-blocking buffer (PBS containing 0.5% AP-free casein [I-block; For studies of the effects of anti-integrin antibodies on recombi-
Tropix, Bedford, MA], 0.01% Tween 20, 0.02% sodium azide) for nant fertilin b-EC binding, ZP-free eggs were incubated with 0.5
either 60 min at room temperature or overnight at 47C. The eggs mg/ml control IgG or anti-integrin IgG in Whitten's medium con-
were then incubated in anti-MBP antibody diluted in AP-blocking taining 22 mM sodium bicarbonate, 15 mg/ml fatty acid-poor BSA
buffer (1:300; New England Biolabs), washed three times in 0.05% for 60 min and then transferred to medium containing the same
casein in PBS, incubated in AP-conjugated goat anti-rabbit IgG antibody (0.3 mg/ml) and 0.5 mg/ml recombinant fertilin b-EC.
(1:104 dilution of 0.6 mg/ml stock; Tropix or Jackson Immunore- Following a 60-min incubation the eggs were washed twice and
search), and then washed nine times in 0.05% casein in PBS and assayed for recombinant fertilin b-EC binding using the luminome-
once in AP assay buffer (20 mM Tris±HCl, pH 9.5; 1 mM MgCl2). tric assay as described above. Binding levels of recombinant fertilin
The egg-associated AP activity was then quanti®ed in a luminome-
b-EC in the presence of GoH3 or b1-B were expressed as a percent-tric assay with a substrate that upon dephosphorylation decom-
age of its binding detected from eggs incubated in control nonim-
poses to an intermediate with the emission of photons. After this
mune IgG.
®nal wash, single eggs were transferred to 25 ml of AP assay buffer
In experiments in which eggs were incubated with both recombi-in a 12 1 75-mm polystyrene tube (one egg per tube). One hundred
nant fertilin b-EC (detected with an anti-rabbit IgG antibody thatmicroliters of enhancer±substrate solution (AP assay buffer con-
cross-reacted with the anti-MBP antibody) and GoH3 antibody (de-taining 25 mM Sapphire II enhancer and 0.4 mM CSPD [disodium
tected with an anti-rat IgG antibody), a species-speci®c goat anti-3-(4-methoxyspiro{1,2-dioxetane-3,2* - (5* -chloro)tricyclo
rabbit IgG secondary antibody was used (Jackson Immunoresearch);[3.3.1.13,7]decan}-4-yl)phenyl phosphate] substrate; Tropix) were
control experiments veri®ed that this antibody did not cross-reactadded to each tube that was incubated for 20 min at room tempera-
with the GoH3 antibody (data not shown). Experiments in whichture. The addition of substrate±enhancer solution was staggered
the effects of rabbit anti-integrin antibodies (b1-B) were tested wereby 15-sec intervals to ensure that each tube was assayed for photon
complicated by the fact that the AP-conjugated goat anti-rabbit IgGemission 20 min following substrate addition. Photon emission
secondary antibodies detects both the anti-integrin antibody andwas measured by raw light units (RLUs) detected over a 10-sec
the anti-MBP antibody used to detect bound recombinant fertilinduration (RLU/10 sec) in a Monolight 2010 luminometer (Analyti-
b-EC. Unfortunately, we were unable to identify an anti-b1 anti-cal Luminescence Laboratory, San Diego, CA).
body that was not made in rabbit that cross-reacted with mouse
egg b1 and inhibited sperm or recombinant fertilin b-EC binding
(data not shown); b1-B was the only antibody that we tested thatAnti-integrin Antibodies
possessed this activity. Therefore, levels of recombinant fertilin b-
EC binding in the presence of b1-B were calculated by subtractingGoH3 (Immunotech, Westbrook, ME) is an anti-a6 rat mono-
the luminometric signal detected from eggs incubated with b1-Bclonal antibody with function-blocking activity (Sonnenberg et al.,
antibody from the signal detected from eggs incubated with b1-B1988b, 1990); this antibody is speci®c for the a6 subunit of the a6b1
antibody plus recombinant fertilin b-EC. It was unlikely that theintegrin heterodimer (Sonnenberg et al., 1988a) and immunoprecip-
signal from eggs incubated with b1-B antibody and recombinantitates a6b1 from mouse eggs (Tarone et al., 1993). An anti-rat b1
fertilin b-EC was due to recombinant fertilin b-EC that had com-rabbit polyclonal antibody made to wheat germ agglutinin-puri-
peted off the antibody, since we observed in separate experiments®edb1 subunit (Albelda et al., 1989) (provided by the laboratory of
that recombinant fertilin b-EC dissociated more readily from eggClayton Buck, Wistar Institute, and hereafter referred to as b1-B)
surfaces than did the b1-B antibody. Speci®cally, levels of boundcross-reacts with several b1-containing integrin heterodimers (So-
b1-B antibody did not decrease following a 60-min culture in thelowska et al., 1991) and immunoprecipitates b1 (but not b3) and
absence of antibody, whereas the levels of bound recombinant fer-several associated a subunits from mouse eggs (Evans et al., 1995a).
tilin b-EC were reduced by 50% when eggs were cultured for 60GoH3 and b1-B were found to bind to live ZP-free mouse eggs
(present report). Other antibodies tested [9EG7, anti-mouse b1 (Re- min in the absence of protein (data not shown).
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In Vitro Fertilization of ZP-Free Eggs
In vitro fertilization was performed and assayed as described
previously (Evans et al., 1995b). Prior to insemination, ZP-free eggs
were incubated in 0.5 mg/ml MBP, recombinant fertilin b-EC, con-
trol IgG, or anti-integrin IgG for 60 min. Eggs were then incubated
in drops (20 eggs per 10 ml drop) containing the same protein or
antibody (at 0.3 mg/ml) and sperm (sperm concentrations used were
10,000, 25,000, and 100,000 sperm/ml, as indicated in the ®gure
legends). As described previously, we observed only acrosome-re-
acted sperm bound to egg plasma membranes (Evans et al., 1995b).
Control experiments veri®ed that sperm motility, sperm±egg bind-
ing, sperm±egg fusion, and development to the pronuclear stage
were comparable in WHITCO and Whitten's medium (data not
shown). Moreover, sperm motility, sperm±egg binding, sperm±egg
fusion were comparable in inseminations in Whitten's medium,
Whitten's medium containing WHITCO buffer, Whitten's medium
containing 0.3 mg/ml MBP, and Whitten's medium containing 0.3
mg/ml control nonimmune IgG (data not shown).
RESULTS
Preparation of Recombinant Fertilin b-EC
Recombinant fertilin b-EC was puri®ed from bacterial
extracts using an amylose-af®nity resin that binds to the
MBP fusion partner. This fusion protein, however, formed
large multimeric aggregates that migrated near the top of
the gel under nonreducing conditions (Fig. 1C, lane 1). This
was likely due to the formation of intermolecular disul®de
bonds in the periplasmic space of the bacteria during IPTG-
induced expression; it should be noted that the extracellular
region of fertilin b contains 34 cysteines residues (Evans et FIG. 1. Design and expression of recombinant fertilin b extracel-
lular domain (recombinant fertilin b-EC) fusion protein. (A) Sche-al., 1995b; Wolfsberg et al., 1995b). Following reduction
matic representation of the domain structure of fertilin b. (B) Con-with DTT, a polypeptide of Mr  78,000, the predicted size
struction of the recombinant fertilin b-EC expression plasmidof this fusion protein based on deduced amino acid se-
(pMAL-b.10) via ligation of the region encoding the predicted extra-quence, was observed (Figs. 1C, lane 2, and 1D, lane 2).
cellular domain of b subunit of mouse fertilin (Evans et al., 1995b)Furthermore, when the DTT was removed by dialysis, the
to the coding region of MBP (mal E) in the parental vector pMAL-recombinant fertilin b-EC formed intramolecular disul®de
p2. (C) Silver-stained SDS gel of preparations of recombinant fertilin
bonds, as evidenced by the presence of a polypeptide of Mr b-EC puri®ed by af®nity chromatography on amylose resin run 68,000 under nonreducing conditions (Figs. 1C, lane 3, under nonreducing conditions. Lane 1, the protein in the form as
and 1D, lane 1) and Mr  78,000 under reducing conditions it is eluted off the amylose af®nity column. When subjected to
(Fig. 1D, lane 2). This reduction-oxidation protocol was nec- SDS±PAGE under nonreducing conditions, the fusion protein ex-
ists as large multimeric aggregates that migrate near the top of theessary for the recombinant fertilin b-EC to have egg-binding
gel. Lane 2, the effect of reducing recombinant fertilin b-EC withactivity, as the nonreduced multimers did not bind to eggs
20 mM DTT. The fusion protein now migrates with an Mr 78,000,(data not shown). Immunoblotting of recombinant fertilin
presumably due to the reduction of intermolecular disul®de bonds.b-EC using anti-MBP antibodies demonstrated that recom-
Lane 3, the effect of oxidizing recombinant fertilin b-EC by dialysisbinant fertilin b-EC prepared by this reduction-oxidation
of DTT from the preparation shown in lane 2. The recombinantprotocol cross-reacted with the anti-MBP antibody and
fertilin b-EC apparently has now formed intramolecular disul®de
showed the characteristic shifts in electrophoretic mobility bonds and migrates with an Mr 68,000. (D) Immunoblot of recom-
expected with the forming and breaking of disul®de bonds binant fertilin b-EC (r-Fb) and MBP with an anti-MBP antibody
(Fig. 1D, lanes 1 and 2). As anticipated, MBP (Mr  43,000) under reducing (/DTT) and nonreducing conditions (0DTT)). Lane
did not show these shifts in electrophoretic mobility under 1, recombinant fertilin b-EC, nonreduced; lane 2, recombinant fer-
tilin b-EC, reduced; lane 3, MBP, nonreduced; lane 4, MBP, reduced.these conditions (Fig. 1D, lanes 3 and 4), since MBP does
not contain cysteine residues (data not shown).
Qualitative and Quantitative Analysis of Binding detected using immunocytochemistry. Recombinant fer-
of Recombinant Fertilin b-EC to Eggs tilin b-EC bound to the microvillar region of ZP-free eggs,
the region to which sperm bind and fuse (Yanagimachi,The recombinant fertilin b-EC subjected to this reduc-
tion-oxidation protocol was able to bind to ZP-free eggs as 1994) (Fig. 2A). Binding to the amicrovillar region overlying
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were de®ned as 100% (Fig. 4). Control proteins, such as
MBP (Fig. 4A) and rabbit IgG (data not shown), produced
signals 100±250% that of signals from control eggs incu-
bated in buffer. The binding of recombinant fertilin b-EC
to eggs was also observed to be concentration dependent
(Fig. 4B). For the experiments described below, eggs were
incubated in 0.5 mg/ml recombinant fertilin b-EC.
Inhibition of Binding of Recombinant Fertilin b-EC
to Eggs by QDE-Containing Peptides
FIG. 2. Immunocytochemical detection of recombinant fertilin We and others have previously shown that peptides corre-
b-EC binding to eggs. ZP-free mouse eggs prepared by acid-treat- sponding to the disintegrin domain of mouse (QDE) or
ment were incubated with 0.5 mg/ml recombinant fertilin b-EC
(A) or 0.5 mg/ml MBP (B), washed, ®xed, and then processed for
immuno¯uorescence using an anti-MBP primary antibody and a
Texas red-conjugated secondary antibody as described under Mate-
rials and Methods. (A) An egg showing binding of recombinant
fertilin b-EC to its microvillar region. (B) An egg showing lack of
binding of MBP to its plasma membrane. The asterisk indicates
the location of the amicrovillar region, as localized by observing
the meiotic chromosomes with DAPI.
the meiotic spindle, a region to which sperm do not bind,
was never observed. Control eggs, incubated in either
WHITCO buffer (data not shown) or with MBP (Fig. 2B), did
not show any visible ¯uorescence on their surfaces. The
observation that recombinant fertilin b-EC bound to the
plasma membranes of eggs demonstrated that this protein
has cell adhesive activity and suggested that the fertilin b
subunit on sperm could mediate the binding of the gamete
plasma membranes.
To complement the qualitative data from the immuno-
¯uorescence assay, we developed a luminometric assay to
quantify the levels of recombinant fertilin b-EC binding.
We ®rst tested the detection of AP activity associated with
goat-anti-rabbit IgG antibodies (GAR-AP); it should be
noted that photon emission from samples of GAR-AP pro-
cessed by this protocol could vary from day to day and with
different sources of GAR-AP (data not shown). The rate of
photon emission increased linearly through a range of GAR-
AP concentrations [0±30 fg as shown (Fig. 3A), and continu-
ing up to 75 fg]. Moreover, photon emission gradually in-
creased with time and plateaued 20 min following substrate
addition to the samples containing various dilutions of
GAR-AP (Fig. 3B). We therefore read the samples after a 20-
min incubation with substrate.
The binding of recombinant fertilin b-EC to a single egg
that had been ®xed and labeled with anti-MBP antibodies
could be readily quanti®ed with this assay (Fig. 4). The pho-
ton emission signal from eggs and the signal-to-noise ratio
FIG. 3. Characterization of the luminometric assay for the detec-(i.e., signals from eggs incubated in recombinant fertilin b-
tion of goat anti-rabbit IgG (GAR)-associated alkaline phosphataseEC compared to signals from eggs incubated in buffer only)
(AP) activity. (A) Concentration dependence of photon emission as
were highly dependent on the concentration of secondary a function of the amount of GAR-AP. (B) Time course of changes
antibody (GAR-AP). For these experiments we used GAR- in the rate of photon emission. AP activity of different amounts of
AP at a dilution of 1:104 (0.06 mg/ml) and detected signals GAR-AP were assayed during a 40-min time period. Amounts of
from eggs incubated in recombinant fertilin b-EC 1200% GAR-AP used were as follows: 0 fg (l); 1.5 fg (m); 15 fg (j); 150 fg
(.). Note that the rate plateaus at approximately 20 min.of control eggs incubated in buffer alone; control signals
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guinea pig (TDE) fertilin b can inhibit fertilization in vitro
(Myles et al., 1994; Almeida et al., 1995; Evans et al., 1995b).
In our previous studies, 0.5 mM CAQDEC reduced sperm
binding by 71%; this inhibition was concentration-depen-
dent, as lower concentrations (0.25 mM and less) did not
cause a statistically signi®cant decrease in sperm binding
(Evans et al., 1995b). Similarly, 0.5 mM CAQDEC peptide
reduced the binding of the recombinant fertilin b-EC to eggs
(Fig. 5). The extent of inhibition of recombinant fertilin b-
EC binding with the CAQDEC peptides (26% of binding in
the presence of the control CDEQAC peptide; Fig. 5B) was
FIG. 5. Effect of QDE-containing peptides on the binding of re-similar to the extent of inhibition of sperm binding to the
combinant fertilin b-EC to eggs. (A) The raw data from a representa-egg observed previously (Evans et al., 1995b).
tive experiment in which at least 10 individual eggs were analyzed
for each group by the luminometric assay. (B) Summarized data
Effect of Chymotrypsin Treatment of Eggs on from three individual experiments in which the binding of recombi-
Recombinant Fertilin b-EC Binding nant fertilin b-EC in the presence of the control peptide (CDEQAC)
was set as 100% and its binding in the presence of the experimentalThe observation that treatment of eggs with chymotryp-
peptide (CAQDEC) was expressed relative to that observed in the
sin or trypsin reduces sperm binding to mouse eggs and presence of the control peptide. In this and subsequent ®gures, the
data presented are from experiments using at least two different
preparations of recombinant fertilin b-EC. In subsequent ®gures,
only summarized data are shown.
subsequent sperm±egg fusion (Boldt et al., 1988) suggests
that an egg surface protein(s) mediate sperm±egg interac-
tions. Accordingly, we examined if chymotrypsin treatment
of ZP-free eggs reduced the ability of recombinant fertilin
b-EC to bind to egg membranes. Eggs treated with 1 mg/
ml chymotrypsin for 20 min [conditions used by others
(Boldt et al., 1988, 1989; Kellom et al., 1992)] showed a
reduced ability to support recombinant fertilin b-EC bind-
ing (Fig. 6). Chymotrypsin-treated eggs bound 50% the
amount of recombinant fertilin b-EC as compared to un-
treated eggs.
Effects of Divalent Cations on the Binding of
Recombinant Fertilin b-EC to Eggs
Since it is well known that several cell adhesion mole-
cules function in a divalent cation-dependent manner (Ta-
keichi, 1990; Haas and Plow, 1994), we previously charac-
terized the divalent cation dependence of mouse sperm±egg
membrane interactions (Evans et al., 1995b). To extend our
studies and to characterize recombinant fertilin b-EC's ac-
tivity as a cell adhesion molecule, we examined the divalent
cation dependence of the interaction of recombinant fertilin
b-EC with egg plasma membranes. The luminometric assay
FIG. 4. Luminometric assay for detecting the binding of recombi- revealed that recombinant fertilin b-EC binding to eggs was
nant fertilin b-EC to eggs. (A) Luminometric signals detected from supported by divalent cations (Fig. 7). Binding of recombi-
individual eggs incubated in buffer, 0.5 mg/ml MBP, or 0.5 mg/ml nant fertilin b-EC to eggs was reduced in nonsupplemented
recombinant fertilin b-EC (rFb-EC), respectively. (B) Concentration
divalent cation-de®cient Whitten's medium (72% of leveldependence of the luminometric signal detected from individual
of binding observed in Whitten's medium, which containseggs incubated in various concentrations of recombinant fertilin
2.4 mM Ca2/ and 1.2 mM Mg2/; Fig. 7). The addition of 0.5b-EC. Shown are representative experiments in which at least 10
mM EGTA to divalent cation-de®cient Whitten's mediumindividual eggs were analyzed for each group. The data presented
in this and subsequent ®gures are expressed as the mean { SEM. further reduced the binding of recombinant fertilin b-EC
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FIG. 8. Effects of recombinant fertilin b-EC on sperm binding to
eggs during fertilization in vitro. ZP-free eggs were prepared by
acid treatment (Experiments 1±6) or by chymotrypsin-mechanical
treatment (Experiments 7±8). The experiments were conducted us-FIG. 6. Effect of chymotrypsin treatment of ZP-free eggs on the
ing the proteins (MBP or recombinant fertilin b-EC) at 0.5 mg/mlbinding of recombinant fertilin b-EC. ZP-free eggs were prepared
and the following sperm concentrations: 10,000 sperm/ml (Experi-by acid treatment and then either treated with 1 mg/ml chymotryp-
ment 1); 25,000 sperm/ml (Experiments 2±5, and 7); and 100,000sin for 20 min at 377C or left untreated and then allowed to recover
sperm/ml (Experiments 6 and 8). Open bars, MBP; closed bars, re-for 60 min. Binding of recombinant fertilin b-EC was then deter-
combinant fertilin b-EC. Each pair of bars represents an individualmined using the luminometric assay. The data are summarized
experiment, with 15±30 eggs examined for each group per experi-from three individual experiments, assaying 8±12 individual eggs
ment. Asterisks indicate those experiments in which the decreasedper group per experiment, and the binding data are expressed as
sperm binding observed in the recombinant fertilin b-EC-treatedthe mean percentage of untreated control { SEM. (i.e., the average
samples was statistically signi®cant (P  0.05, t test) as comparedRLU/10 sec minus background [average RLU/10 sec of control eggs
to the MBP control samples. In the experiments presented hereincubated in the absence of recombinant fertilin b-EC] of untreated
and in Fig. 10, the following control levels of sperm binding wereeggs incubated in recombinant fertilin a-EC is de®ned as 100%).
observed: 1.25 { 0.27 sperm/acid-treated egg following insemina-
tions using 10,000 sperm/ml; 2.93 { 0.35 sperm/acid-treated egg
and 1.28 { 0.37 sperm/CTM-treated egg following inseminations
using 25,000 sperm/ml; and 5.71 { 1.24 sperm/acid-treated egg and(39% of the binding observed in Whitten's; Fig. 7). This
3.58 { 0.45 sperm/CTM-treated egg following inseminations using
suggested that trace amounts of divalent cations in the diva- 100,000 sperm/ml.
lent cation-de®cient medium still supported some binding.
All three individual divalent cations tested (2.0 mM Ca2/,
Mn2/, or Mn2/) supported the binding of recombinant fer-
tilin b-EC to eggs at levels similar to that observed to eggs
in Whitten's medium (Fig. 7). These results were similar to
our previous observation that sperm±egg binding is sup-
ported by the presence of Ca2/, Mg2/, or Mn2/ as the only
divalent cation in the medium (Evans et al., 1995b).
Inhibition of Sperm Binding to Eggs during in
Vitro Fertilization by Recombinant Fertilin b-EC
Sperm±egg binding is inhibited by synthetic peptides that
contain the tripeptide QDE corresponding to the disintegrin
FIG. 7. Effects of divalent cations on the binding of recombinant domain of fertilin b (Almeida et al., 1995; Evans et al.,
fertilin b-EC to eggs. ZP-free eggs were prepared by acid treatment 1995b). Accordingly, we tested the ability of recombinant
and binding of recombinant fertilin b-EC was determined using the fertilin b-EC to inhibit sperm±egg binding (Fig. 8). Recom-
luminometric assay. Whitten's medium contains 2.4 mM Ca2/ and binant fertilin b-EC (0.5 mg/ml, i.e., 6.4 mM) was used be-
1.2 mM Mg2/. 0 mM D.C., divalent cation-de®cient medium. The cause this concentration showed a high level of binding (Fig.
data are expressed as the binding relative to that observed in Whit-
3); 0.25 mg/ml displayed lower levels of binding (Fig. 3B) andten's medium. The experiment was performed three times, assaying
did not signi®cantly reduce sperm±egg binding in initial8±12 individual eggs per group per experiment. Asterisks indicate
experiments (data not shown).samples in which the decreased binding of recombinant fertilin b-
Previous work examining the effect of QDE peptides onEC was statistically signi®cant as compared to binding in the con-
trol, Whitten's medium (P  0.03, t test). sperm binding (Almeida et al., 1995) used an IVF system
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very different from ours. Speci®cally, Almeida et al. (1995)
performed their IVF experiments using very high sperm con-
centrations (0.5±1 1 106/ml) and CTM-treated eggs,
whereas we routinely use 10,000±25,000 sperm/ml and
acid-treated eggs. Therefore, to mimic both our previous
conditions (Evans et al., 1995b) and those of Almeida et al.
(1995), we performed experiments using two different ZP
removal methods (acid treatment and CTM treatment) and
three different sperm concentrations to study the effect of
recombinant fertilin b-EC on sperm binding. In our IVF
system, we generally used 10,000 or 25,000 sperm/ml when
inseminating ZP-free eggs since this protocol generally re-
sults in one to three sperm bound per egg. We chose these
sperm concentrations because in IVF of ZP-intact eggs, we
have observed that usually one to three sperm are found in
FIG. 9. Effects of recombinant fertilin b-EC containing or lackingthe perivitelline space, and that the incidence of polyspermy
the disintegrin domain on sperm binding to eggs during fertilization
is very low (data not shown). The concentration of sperm in vitro. Acid-treated ZP-free eggs were incubated in Whitten's
used in IVF affects the resulting levels of binding; more medium containing the indicated protein (MBP, recombinant fer-
sperm bind and fuse with increasing concentrations of tilin b-EC, or recombinant fertilin b-EC lacking the disintegrin
sperm (e.g., see Table 1 in Evans et al., 1995b). For the domain at 0.5 mg/ml) and then inseminated with either 25,000
or 100,000 sperm/ml. The data are summarized from four (25,000present studies, in addition to our standard method of using
sperm/ml) or ®ve (100,000 sperm/ml) individual experiments and10,000±25,000 sperm/ml, we also used 100,000 sperm/ml
are expressed as a mean percentage of the sperm binding (measuredfor the purpose of mimicking the conditions of Almeida et
as average number of sperm bound per egg) observed as comparedal. (1995). We chose not to use a higher sperm concentra-
to the sperm binding to eggs treated with the control protein, MBP.
tion, as concentrations 200,000 sperm/ml usually pro- Open bars, recombinant fertilin b-EC, which includes the disinte-
duced a signi®cant number (20%) of polyspermic eggs in grin domain; closed bars, recombinant fertilin b-EC lacking the
our IVF system (data not shown). disintegrin domain. In the experiments presented here, the follow-
In all experiments using these various conditions, sperm ing levels of sperm binding were observed for MBP-treated controls:
1.75 { 0.20 sperm/egg following inseminations using 25,000binding to recombinant fertilin b-EC-treated eggs was re-
sperm/ml, and 7.37 { 0.37 sperm/egg following inseminations us-duced as compared to binding to control eggs, ranging 8±
ing 100,000 sperm/ml.60% of control levels and averaging 35% (Fig. 8). Recombi-
nant fertilin b-EC did not appear to inhibit sperm±egg fu-
sion directly (examined further in Evans et al., 1997). We
observed that sperm that were able to bind to eggs were
Effects of Anti-integrin Antibodies on Spermalso able to fuse with the egg's plasma membrane (data not
Binding to ZP-Free Eggsshown). This same observation has been made with QDE
peptides (Almeida et al., 1995; Evans et al., 1995b), echi- An egg integrin has been hypothesized to serve as a bind-
statin (Bronson et al., 1995), and anti-a6 antibodies (Almeida ing site for fertilin b on sperm (Blobel et al., 1992; Myles,
et al., 1995), where sperm binding is reduced, but bound 1993). In the experiments reported by Almeida et al. (1995),
sperm can still fuse with peptide-, protein-, or antibody- an anti-b1 polyclonal antibody partially inhibited sperm±
treated eggs. egg binding, and an anti-a6 function-blocking monoclonal
We also examined the effects on sperm binding of a form antibody GoH3 almost completely blocked sperm±egg
of recombinant fertilin b-EC that lacks the disintegrin do- binding. Since these results implicated a6b1 in sperm bind-
main; this protein binds to the microvillar region of eggs ing to eggs, and because fertilin b has a domain with homol-
(as determined by immunocytochemistry) with a similar ogy to an integrin ligand, we examined whether this particu-
concentration dependence (as determined by the luminome- lar egg integrin has a role in the binding of recombinant
tric assay) as does recombinant fertilin b-EC (data not fertilin b-EC to eggs.
shown). Eggs incubated and then inseminated in the pres- Prior to these studies, however, we tested the effects of
ence of recombinant fertilin b-EC lacking the disintegrin anti-integrin antibodies on sperm±egg interactions in our
domain bound more sperm than did eggs incubated and then IVF system, since, as noted above, our IVF system differed
inseminated in the presence of recombinant fertilin b-EC from that used by Almeida et al. (1995) in two important
which includes the disintegrin domain (Fig. 9). This obser- aspects, namely, ZP removal and sperm concentration. We
vation suggests that the disintegrin domain either includes tested the ability of different anti-integrin antibodies to in-
amino acids that are recognized by an egg binding site(s) or hibit sperm±egg binding by inseminating both acid-treated
contributes sequence information required for the proper and CTM-treated eggs in vitro in different sperm concentra-
tions in the presence of the antibodies. An anti-b1 poly-folding of domain(s) involved in egg interactions.
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clonal antibody moderately inhibited sperm binding to both
acid-treated and CTM-treated eggs (averages of 69 and 58%
of sperm binding to eggs in control IgG, respectively) (Fig.
10A). The function-blocking anti-a6 antibody GoH3 did not
inhibit sperm binding to acid-treated eggs (average of 102%
of controls) (Fig. 10B). However, the GoH3 antibody did
inhibit sperm binding to CTM-treated eggs (average 37% of
controls; Fig. 10B); generally, 1±2 sperm were bound to
CTM-treated eggs incubated in GoH3 antibody, in agree-
ment with Almeida et al. (1995). It should be noted that
when the GoH3 antibody and recombinant fertilin b-EC
were tested in parallel for their abilities to inhibit sperm
FIG. 11. Binding of anti-integrin antibodies to acid- and CTM-
treated eggs. (A) Binding of GoH3 antibody, an anti-a6 antibody, to
acid- or CTM-treated eggs as determined by the luminometric
assay. The experiment was conducted 3 times. (B) Binding of b1-B
antibody to acid- or CTM-treated eggs as determined by the lumino-
metric assay. The experiment was conducted 5 times, assaying 8±
12 individual eggs per group per experiment. The data are expressed
relative to the binding of the respective control IgGs (i.e., average
RLU/10 sec detected from eggs incubated in control IgG). For both
A and B, the differences in binding are signi®cant (P  0.03, t test).
binding to acid-treated eggs, recombinant fertilin b-EC had
an inhibitory effect but the GoH3 antibody did not (data
not shown). The antibodies also did not inhibit sperm±egg
fusion (data not shown), in agreement with the ®ndings of
Almeida et al. (1995).
Effects of Different ZP Removal Methods on the
Ability of ZP-Free Eggs to Bind Anti-integrin
Antibodies, Sperm, and Recombinant Fertilin b-EC
Almeida et al. (1995) and we observed that GoH3 inhibited
sperm binding to CTM-treated eggs, whereas we observed that
GoH3 had no effect on sperm binding to acid-treated eggs (Fig.
10B). To ascertain if the difference in the method used to
prepare ZP-free eggs accounted for the difference in the ability
of GoH3 antibody to inhibit sperm binding, we compared the
ability of anti-integrin antibodies to bind to acid-treated and
CTM-treated eggs. Using both immunocytochemistry (data
not shown) and the luminometric assay (Fig. 11A), we ob-
FIG. 10. Effects of anti-integrin antibodies on sperm binding to
served that CTM-treated eggs bound signi®cantly more GoH3eggs during fertilization in vitro. (A) Effect of b1-B antibody, an
antibody than did acid-treated eggs (539% and 218% of IgG-anti-b1 integrin antibody, on sperm binding. (B) Effect of GoH3
treated controls, respectively) (Fig. 11A), suggesting that thisantibody, an anti-a6 integrin antibody, on sperm binding. ZP-free
functional epitope of the a6 integrin is modi®ed by the acideggs were prepared by acid treatment or by chymotrypsin-mechani-
cal treatment (as indicated at the top of each panel). The experi- treatment such that the epitope cannot be recognized by the
ments were conducted using the antibodies at 0.5 mg/ml and the GoH3 antibody. In contrast, the anti-b1 polyclonal antibody
following sperm concentrations: 10,000 sperm/ml (A, Experiments (b1-B) bound very well to both CTM-treated eggs and acid-
1 and 6; B, Experiments 1 and 2); 25,000 sperm/ml (A, Experiments treated eggs (1847% and 1242% of IgG-treated control eggs,
2, 3, and 7; B, Experiments 3, 4, and 8); and 100,000 sperm/ml (A, respectively) (Fig. 11B).
Experiments 4, 5, 8, and 9; B, Experiments 5, 6, 7, 9, and 10). Open In contrast to the ®nding that the GoH3 antibody bound
bars, control IgG; closed bars, b1-B (A) or GoH3 (B). Each pair of bars better to CTM-treated eggs than to acid-treated eggs, spermrepresents an individual experiment, with 15±30 eggs examined for
and recombinant fertilin b-EC bound better to acid-treatedeach group per experiment. Asterisks indicate those experiments
eggs than to CTM-treated eggs (Fig. 12). It should also bein which the decreased sperm binding observed in the appropriate
noted that we observed that recombinant fertilin b-EC dis-anti-integrin antibody was statistically signi®cant (P  0.05, t test)
as compared to control IgG samples. sociated from egg surfaces more readily than did the GoH3
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inhibition of the binding of sperm fertilin b, we tested the
ability of anti-integrin antibodies to inhibit the binding of
recombinant fertilin b-EC to eggs. GoH3-treated eggs bound
virtually equal amounts of recombinant fertilin b-EC as
did control IgG-treated eggs, suggesting that GoH3 had no
inhibitory effect on acid-treated eggs (96% of control; Fig.
13). This was expected since acid-treated eggs bound rela-
tively little of the GoH3 antibody as compared to CTM-
treated eggs (Fig. 11A). However, GoH3 antibody also had
very little inhibitory effect on the binding of recombinant
fertilin b-EC to CTM-treated eggs; GoH3-treated eggs
bound very similar amounts of recombinant fertilin b-EC
as did control IgG-treated eggs (86% of control; Fig. 13).
FIG. 12. Binding of sperm or recombinant fertilin b-EC binding This was surprising since the GoH3 antibody binds well to
to acid- and CTM-treated eggs. (A) ZP-free eggs (acid-treated and CTM-treated eggs (Fig. 11A) and this antibody inhibited
CTM-treated) were inseminated with 100,000 sperm/ml and the sperm±egg binding to CTM-treated eggs (Almeida et al.,
number of sperm bound was determined. The experiment was per- 1995; Fig. 10B, this study). In contrast, the anti-b1 poly-formed 5 times. (B) The amount of recombinant fertilin b-EC bind-
clonal antibody, b1-B, reduced the binding of recombinanting to acid- and CTM-treated eggs was determined using the lumi-
fertilin b-EC to both acid-treated eggs and CTM-treated eggsnometric assay. The experiment was performed 7 times, assaying
(to 48 and 29% that of control levels, respectively; Fig. 13).8±12 individual eggs per group per experiment, with the data ex-
This was in agreement with the observation that this anti-pressed as the mean { SEM as the percentage of the control (i.e.,
body inhibits sperm binding to both acid-treated and CTM-average RLU/10 sec detected from acid- or CTM-treated eggs incu-
bated in buffer). treated eggs to a moderate extent (Almeida et al., 1995; Fig.
10A, this study).
DISCUSSION
or b1-B antibodies (data not shown). Acid-treated and CTM-
treated eggs were incubated with recombinant fertilin b- Fertilin b and other family members of its molecular fam-
EC, GoH3 antibody, or b1-B antibody for 60 min, and then ily (ADAMs or MDCs; Wolfsberg et al., 1995a) have been
either ®xed immediately or washed and incubated for 60
min in the absence of protein or antibody. We found that
eggs incubated with the GoH3 or b1-B antibodies had equal
amounts of antibody bound to them when compared to anti-
body-treated eggs that were ®xed immediately (data not
shown). In contrast, washed eggs had approximately 50%
the amount of bound recombinant fertilin b-EC when com-
pared to recombinant fertilin b-EC-treated eggs that were
®xed immediately (data not shown). Identical results were
obtained with both acid-treated and CTM-treated eggs, with
the exception that more recombinant fertilin b-EC and less
GoH3 antibody bound to acid-treated eggs than to CTM-
treated eggs (as shown in Figs. 11 and 12).
To summarize, the observation of the relatively low lev-
els of GoH3 epitope on acid-treated eggs explained our in-
ability to inhibit sperm binding to acid-treated eggs with
the GoH3 antibody (Figs. 10B and 11A). However, this result FIG. 13. Effects of anti-integrin antibodies on the binding of re-
presented a paradox. Acid-treated eggs displayed less of the combinant fertilin b-EC to acid- and CTM-treated eggs. ZP-free
eggs (acid-treated or CTM-treated, as indicated in the ®gure) werefunctional GoH3 a6 epitope implicated in sperm±egg bind-
incubated in 0.5 mg/ml of the indicated anti-integrin antibodying (Almeida et al., 1995) and yet these acid-treated eggs
(GoH3 or b1-B) for 60 min and then incubated in 0.5 mg/ml ofbound more sperm and greater amounts of recombinant fer-
recombinant fertilin b-EC and 0.3 mg/ml of the indicated antibodytilin b-EC than did CTM-treated eggs (Fig. 12).
for 60 min. Recombinant fertilin b-EC binding to eggs was deter-
mined using the luminometric assay. The experiment was per-
formed four times, assaying 8±12 individual eggs per group perEffects of Anti-integrin Antibodies on the Binding
experiment and shown are the summarized data. The data are ex-of Recombinant Fertilin b-EC to ZP-Free Eggs
pressed as a percentage of the binding observed as compared to the
To examine if the inhibitory effect of the anti-b1 and binding of recombinant fertilin b-EC to eggs treated with control
IgG. Closed bars, GoH3-treated eggs. Open bars, b1-B-treated eggs.anti-a6 integrin antibodies on sperm binding was due to an
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proposed to represent a new class of cell adhesion molecules et al., 1988). Finally, also in agreement with previous stud-
ies of mouse sperm binding (Evans et al., 1995b), we observebased on their deduced amino acid sequence (Blobel et al.,
1992; Wolfsberg et al., 1995a). The evidence for this, how- that the binding of recombinant fertilin b-EC to eggs is
dependent on divalent cations (Fig. 7). Binding levels in di-ever, is indirect and is based solely on the disruption of
cell±cell interactions with peptides corresponding to the valent cation-de®cient medium containing 0.5 mM EGTA
are 39% of the binding levels observed in control medium,disintegrin domain of fertilin b (Myles et al., 1994; Almeida
et al., 1995; Evans et al., 1995b). We present here the ®rst Whitten's medium (which contains 2.4 mM Ca2/ and 1.2
mM Mg2/). All three individual divalent cations tested,direct evidence that the fertilin b subunit has cell adhesive
activity, namely, that a recombinant form of the putative Ca2/, Mg2/, and Mn2/ (2.0 mM) are each capable of support-
ing similar levels of binding of recombinant fertilin b-EC,extracellular domain of the fertilin b subunit (recombinant
fertilin b-EC) binds to the microvillar region of ZP-free eggs, suggesting that one divalent cation can substitute for an-
other and that none of these divalent cations inhibits bind-the region to which sperm bind. It is possible that fertilin
b dimerized with fertilin a may have additional or different ing. This agrees with our ®ndings on the divalent cation
dependence of sperm±egg binding (Evans et al., 1995b). Theactivities. It should also be noted that the native fertilin a/
b heterodimer on sperm, fertilin a/b heterodimer puri®ed divalent cation dependence of fertilin b-EC binding to eggs
implies that the conformation of the fertilin b ligand onfrom sperm, or recombinant fertilin subunit(s) expressed in
a eukaryotic system may fold differently from recombinant sperm and/or the binding partner(s) on eggs requires diva-
lent cations. This is not surprising as several families offertilin b-EC that is expressed in bacteria and renatured as
described, and thus these proteins may have additional or cell adhesion molecules, including cadherins and some inte-
grins, recognize their ligands in a divalent cation-dependentdifferent properties. Nevertheless, this binding ability of
recombinant fertilin b-EC suggests that the fertilin b sub- manner (Takeichi et al., 1990; Haas and Plow, 1994; Loftus
et al., 1994).unit has adhesive activity by itself, i.e., fertilin b does not
need to be expressed as a heterodimer with the fertilin a Several groups have suggested that egg integrins mediate
sperm±egg membrane interactions (Bronson and Fusi, 1990;subunit or any other ADAM family member to bind to eggs.
Moreover, these results also suggest that fertilin b does not Anderson et al., 1993; Almeida et al., 1995; Bronson et al.,
1995). The ®nding that an a6 function-blocking antibody,require either the putative transmembrane or cytoplasmic
domains for its adhesive activity. Finally, since bacterially GoH3, inhibits sperm binding, coupled with the ability of
an a6-de®cient cell line transfected with an a6 expressionexpressed recombinant fertilin b-EC is not glycosylated,
glycosylation is not required for the recombinant protein plasmid to bind sperm, suggests that an a6 egg integrin par-
ticipates in sperm±egg interactions (Almeida et al., 1995).to have adhesive activity.
The binding properties of recombinant fertilin b-EC are Fertilin b has been proposed to be a ligand for a6b1 based
on the observations that fertilin b contains a disintegrinsimilar to those of sperm in three ways: (a) reduced binding
in the presence of CAQDEC peptides; (b) reduced binding domain (Blobel et al., 1992; Evans et al., 1995b; Wolfsberg
et al., 1995b), and that peptides corresponding to the disinte-to chymotrypsin-treated eggs; and (c) the divalent cation
dependence of binding. These points are elaborated as fol- grin domain have been reported to reduce the binding of
GoH3 antibody to egg surfaces (Almeida et al., 1995). Ourlows. CAQDEC peptides corresponding to the disintegrin
domain inhibit recombinant fertilin b-EC binding to eggs studies with anti-integrin antibodies support the hypothesis
that a b1 integrin(s) on eggs is involved in sperm and recom-(Fig. 5) in a manner similar to the way they inhibit sperm
binding to eggs (Evans et al., 1995b), suggesting that the binant fertilin b-EC binding. In agreement with Almeida et
al. (1995), we ®nd that an anti-b1 antibody reduces spermbinding of recombinant fertilin b-EC to eggs is mediated,
at least in part, by the QDE-containing disintegrin domain binding (Fig. 10A). More importantly, we present the ®rst
evidence that an egg b1 integrin may serve as a bindingof fertilin b. It has been suggested that, within the disinte-
grin loop CRLAQDECDVTEYC, the actual active tripeptide site for fertilin b on sperm, since this anti-b1 antibody also
reduces the binding of recombinant fertilin b-EC to eggsis ECD, two amino acids toward the carboxy terminus from
the QDE sequence, based on sequence conservation be- (Fig. 13).
The a integrin subunit(s) that is partnered with the b1tween fertilin b in ®ve different species (Perry et al., 1995;
Hardy and Holland, 1996). It should be noted, however, that subunit and that participates in the binding of recombinant
fertilin b-EC has not been identi®ed; this identi®cation willsynthetic peptides that inhibited sperm binding in two dif-
ferent studies did not include the D of the ECD sequence require additional studies that are beyond the scope of the
present paper. The functional a6 epitope identi®ed by the(Myles et al., 1994; Evans et al., 1995b). Nevertheless, it is
possible that this region and/or other regions mediates the monoclonal antibody GoH3 has been proposed to be in-
volved in sperm-egg binding and it has been reported thatbinding of fertilin b to its cognate binding site(s) on eggs.
Recombinant fertilin b-EC appears to interact with a chy- peptides corresponding to the disintegrin domain of fertilin
b to inhibit GoH3 antibody binding to CTM-treated eggsmotrypsin-sensitive site on eggs, since treatment of eggs
with this protease results in eggs with a reduced ability to (Almeida et al., 1995). Nevertheless, the sperm ligand for
egg a6b1 has not been directly identi®ed, and moreover, twobind recombinant fertilin b-EC (Fig. 6). Such treatment also
results in eggs with a reduced ability to bind sperm (Boldt lines of evidence presented here suggest that a6 does not
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8611 / 6x27$$$164 06-18-97 02:36:00 dba
91Recombinant Fertilin b Binding to Mouse Eggs
have signi®cant activity as a binding site for one sperm ceded by a binding or ``docking'' step to bring membranes
in close apposition to each other. Thus, each step may beligand, fertilin b. First, acid-treated eggs bind relatively lit-
tle GoH3 a6 antibody (Fig. 11A) and yet are capable of bind- mediated by a distinct set of ligands and acceptors/recep-
tors. Fertilin b on the sperm and a b1 integrin on the egging more sperm or recombinant fertilin b-EC than do CTM-
treated eggs that display more of the GoH3 a6 epitope on appear to be involved in one component of this process, the
binding of sperm to the egg plasma membrane. In addition,their surfaces (Fig. 12). Thus, the increased amount of the
GoH3 epitope on the surface of CTM-treated eggs does not there are many other candidate molecules, including an a6
integrin, that may also participate in the processes of spermcorrelate with an increased ability of these eggs to bind
sperm or recombinant fertilin b-EC. Second, incubating binding, fusion, and/or incorporation.
Although an a6 integrin has been proposed to mediateeggs in GoH3 antibody prior to and during exposure to re-
combinant fertilin b-EC does not signi®cantly reduce the fertilin b binding to eggs (Almeida et al., 1995) several of
the known binding properties of a6 integrin are inconsistentbinding of recombinant fertilin b-EC to either acid-treated
or CTM-treated eggs (Fig. 13). These results suggest that with this proposal. The ligand for a6b1 in other cell types
is laminin, which is different from the predicted integrinGoH3 a6 epitopes on eggs are not required for either sperm
binding or recombinant fertilin b-EC binding. ligand of fertilin b. Speci®cally, the functional a6 epitope
identi®ed by the GoH3 antibody recognizes a three-dimen-It could be argued that the amounts of the GoH3 a6 epi-
tope on acid-treated eggs, albeit low, are suf®cient to sup- sional structure of the E8 laminin fragment that is com-
posed of laminin a, b, and g chains (Sonnenberg et al., 1990;port recombinant fertilin b-EC binding. If this were true,
the GoH3 antibody should inhibit recombinant fertilin b- Deutzmann et al., 1990). Thus, a6b1 differs from the family
of integrins that recognize short peptide sequences likeEC binding to these eggs, but this is not the case. The GoH3
antibody has no inhibitory effect on the binding of recombi- RGD in other integrin ligands such as ®bronectin, vitronec-
tin, or snake venom disintegrins (Haas and Plow, 1994).nant fertilin b-EC to acid-treated eggs (Fig. 13). In addition,
the GoH3 antibody has very little inhibitory effect on the Laminin has been observed on the surfaces of tails of human
sperm by immuno¯uorescence (Fusi et al., 1992), althoughbinding of recombinant fertilin b-EC to CTM-treated eggs
(Fig. 13), despite the fact that these eggs display signi®cant it is unknown whether this laminin is synthesized and se-
creted during spermatogenesis/spermiogenesis or synthe-amounts of the GoH3 epitope on their surfaces (Fig. 11A)
and that the GoH3 antibody inhibits sperm binding to these sized and secreted by cells of the epididymis and then ad-
heres to the sperm surface during epididymal transit. It iseggs (Almeida et al., 1995, and results reported here, Fig.
10B). It could also be argued that the af®nity of recombinant conceivable that laminin or potentially other proteins on
the surface of sperm could serve as a ligand for a6b1 on eggs.fertilin b-EC for egg a6 is greater than the af®nity of GoH3
antibody and this would explain why GoH3 antibody does In summary, we present the ®rst direct evidence that
fertilin b can function as a cell adhesion molecule in sperm±not inhibit recombinant fertilin b-EC binding to eggs. How-
ever, our observation that recombinant fertilin b-EC disso- egg binding. Furthermore, recombinant fertilin b-EC ap-
pears to interact with a b1-containing egg integrin, providingciates from egg surfaces more readily than does the GoH3
or b1-B antibodies (data not shown) is inconsistent with this the ®rst experimental evidence that members of the ADAM
family of cellular disintegrins can function as integrin li-proposal. Finally, it is possible that recombinant fertilin b-
EC is incapable of being recognized by an a6 integrin on gands. Recombinant fertilin b-EC will also serve as an excel-
lent reagent to identify, in an unbiased manner, integrinseggs, and therefore does not mimic native fertilin b on
sperm. While this is a formal possibility, several of our ob- and possibly other proteins on eggs that serve as binding
partners for this sperm ligand.servations make this unlikely. Recombinant fertilin b-EC
binds to eggs with similar properties as do sperm, and inhib-
its sperm binding to eggs in in vitro fertilization. Moreover,
CAQDEC peptides, corresponding to the disintegrin do- ACKNOWLEDGMENTS
main of fertilin b, inhibit the binding of both sperm and
recombinant fertilin b-EC to eggs. This research was supported by grants from the N.I.H. (HD 22732
One possible explanation for this apparent discrepancy is to G.S.K. and R.M.S., HD 06274 to G.S.K., and HD 22681 to R.M.S.).
that sperm±egg membrane interactions are likely mediated J.P.E. was supported by post-doctoral fellowships from the Ameri-
by multiple sperm ligands and multiple egg membrane ac- can Cancer Society (PF-3675) and the N.I.H. (HD 07903). We thank
Clayton Buck for the anti-b1 antibody.ceptors/receptors. A model similar to this has been proposed
for sperm±ZP interactions (Bleil et al., 1988; Mortillo and
Wassarman, 1991). Sperm±egg membrane interactions oc-
cur in a series of steps, beginning with the sperm binding REFERENCES
to the egg membrane and continuing with the initiation of
fusion via the equatorial segment of the sperm; the process Albelda, S. M., Daise, M., Levine, E. M., and Buck, C. A. (1989).
culminates with the complete incorporation of the entire Identi®cation and characterization of cell-substratum adhesion
sperm head and tail into the egg (Yanagimachi, 1994). In receptors on cultured endothelial cells. J. Clin. Invest. 83, 1992±
2002.addition, each membrane fusion event is likely to be pre-
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8611 / 6x27$$$164 06-18-97 02:36:00 dba
92 Evans, Kopf, and Schultz
Allen, C. A., and Green, D. P. L. (1995). Monoclonal antibodies Evans, J. P., Schultz, R. M., and Kopf, G. S. (1995a). Identi®cation
which recognize equatorial segment epitopes presented de novo and localization of integrin subunits in oocytes and eggs of the
following the A23187-induced acrosome reaction of guinea pig mouse. Mol. Reprod. Dev. 40, 211±220.
sperm. J. Cell Sci. 108, 767±777. Evans, J. P., Schultz, R. M., and Kopf, G. S. (1995b). Mouse sperm-
Almeida, E. A. C., Huovila, A.-P. J., Sutherland, A. E., Stephens, egg plasma membrane interactions: Analysis of roles of egg inte-
L. E., Calarco, P. G., Shaw, L. M., Mercurio, A. M., Sonnenberg, grins and the mouse sperm homologue of PH-30 (fertilin) b. J.
A., Primakoff, P., Myles, D. G., and White, J. M. (1995). Mouse Cell Sci. 108, 3267±3278.
egg integrin a6b1 functions as a sperm receptor. Cell 81, 1095± Evans, J. P., Schultz, R. M., and Kopf, G. S., (1997). Characterization
1104. of the bindery of recombinant mouse sperm fertilin a subunit to
Anderson, D. J., Michealson, J. S., and Johnson, P. M. (1989). Tro- mouse eggs: Evidence for function as a cell adhesion molecule
phoblast/leukocyte-common antigen is expressed by human tes- in sperm-egg binding. Dev. Biol. 187, 94±106.
ticular germ cells and appears on the surface of acrosome-reacted- FeÂnichel, P., Dohr, G., Grivaux, C., Cervoni, F., Donzeau, M., and
sperm. Biol. Reprod. 41, 285±293. Hsi, B.-L. (1990). Localization and characterization of the acroso-
Anderson, D. J., Abbott, A. F., and Jack, R. M. (1993). The role of mal antigen recognized by GB24 on human spermatozoa. Mol.
complement component C3b and its receptors in sperm-oocyte Reprod. Dev. 27, 173±178.
interaction. Proc. Natl. Acad. Sci. USA 90, 10051±10055. Fusi, F. M., and Bronson, R. A. (1992). Sperm surface ®bronectin:
Barker, H. L., Perry, A. C. F., Jones, R., and Hall, L. (1994). Sequence Expression following capacitation. J. Androl. 13, 28±35.
and expression of a monkey testicular transcript encoding tMDC Fusi, F. M., Bronson, R. A., Hong, Y., and Ghebrehiwet, B. (1991).
I, a novel member of the metalloprotease-like, disintegrin-like, Complement component C1q and its receptor are involved in
cysteine-rich (MDC) protein family. Biochim. Biophys. Acta. the interaction of human sperm with zona-free hamster eggs.
1218, 429±431. Mol. Reprod. Dev. 29, 180±188.
Bleil, J. D., Greve, J. M., and Wassarman, P. M. (1988). Identi®cation
Fusi, F. M., Lorenzetti, I., Vignali, M., and Bronson, R. A. (1992).
of a secondary sperm receptor in the mouse egg zona pellucida:
Sperm surface proteins after capacitation: Expression of vitronec-
Role in maintenance of binding of acrosome-reacted sperm to
tin on the spermatozoan head and laminin on the sperm tail. J.
eggs. Dev. Biol. 128, 376±385.
Androl. 13, 488±497.
Blobel, C. P., Myles, D. G., Primakoff, P., and White, J. M. (1990).
Fusi, F. M., Lorenzetti, I., Mangili, F., Herr, J. C., Freemerman, A. J.,Proteolytic processing of a protein involved in sperm-egg fusion
Gailit, J., and Bronson, R. A. (1994). Vitronectin is an intrinsiccorrelates with acquisition of fertilization competence. J. Cell
protein of human spermatozoa released during the acrosome re-Biol. 111, 69±7.
action. Mol. Reprod. Biol. 39, 337±343.Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Prima-
GarcõB a-Framis, V., Martorell, R., Marquez, C., Benet, J., Andolz, P.,koff, P., and White, J. M. (1992). A potential fusion peptide and
and MartõB nez, P. (1994). Inhibition by anti-sperm monoclonalan integrin ligand domain in a protein active in sperm-egg fusion.
antibodies of the penetration of zona-free hamster oocytes byNature 356, 248±252.
human spermatozoa. Immunol. Cell Biol. 72, 1±6.Blum, H., Beier, H., and Gross, H. J. (1987). Improved silver staining
Gould, R. J., Polokoff, M. A., Friedman, P. A., Huang, T.-F., Holt,of plant proteins, RNA, and DNA in polyacrylamide gels. Electro-
J. C., Cook, J. J., and Niewiarowski, S. (1990). Disintegrins: Aphoresis 8, 93±99.
family of integrin inhibitory proteins from viper venoms. Proc.Boldt, J., and Wolf, D. P. (1986). An improved method for isolation
Soc. Exp. Biol. Med. 195, 168±171.of fertile zona-free mouse eggs. Gamete Res. 13, 213±222.
Haas, T. A., and Plow, E. F. (1994). Integrin-ligand interactions: aBoldt, J., Howe, A. M., and Preble, J. (1988). Enzymatic alteration
year in review. Curr. Op. Cell Biol. 6, 656±662.of the ability of mouse egg plasma membrane to interact with
Hardy, C. M., and Holland, M. K. (1996). Cloning and expressionsperm. Biol. Reprod. 39, 19±27.
of recombinant rabbit fertilin. Mol. Reprod. Biol. 45, 107±116.Boldt, J., Gunter, L. E., and Howe, A. M. (1989). Characterization of
Heinlein, U. A. O., Wallat, S., Senftleben, A., and Lemaire, L.cell surfaces polypeptides of unfertilized, fertilized, and protease-
(1994). Male germ cell-expressed mouse gene TAZ83 encodes atreated zona-free mouse eggs. Gamete Res. 23, 91±101.
putative, cysteine-rich transmembrane protein (cyritestin) shar-Bronson, R. A., and Fusi, F. M. (1990). Evidence that an Arg-Gly-
ing homologies with snake toxins and sperm-egg fusion proteins.Asp adhesion sequence plays a role in mammalian fertilization.
Dev. Growth Differ. 36, 49±58.Biol. Reprod. 43, 1019±1025.
Hoshi, K., Sasaki, H., Yanagida, K., Sato, A., and Tsuiki, A. (1994).Bronson, R. A., Gailit, J., Bronson, S., and Oula, L. (1995). Echista-
Localization of ®bronectin on the surface of human spermatozoatin, a disintegrin, inhibits sperm oolemal adhesion but not oocyte
and relation to the sperm-egg interaction. Fert. Steril. 61, 542±penetration. Fert. Steril. 64, 414±420.
547.Buck, C. A., Shea, E., Duggan, K., and Horwirz, A. F. (1986). Integrin
Jin, M., Larsson, A., and Nilsson, B. O. (1996). Monoclonal antibod-(the CSAT antigen): Functionality requires oligomeric integrity.
ies against unfertilized zona-free mouse oocytes: Characteriza-J. Cell Biol. 103, 2421±2428.
tion and effects on fertilization. Mol. Reprod. Dev. 43, 47±54.CuasnicuÂ , P. S., Gonzalez-Echeverria, M. F., Piazza, A. D., Cameo,
Kellom, T., Vick, A., and Boldt, J. (1992). Recovery of penetrationM. S., and Blaquier, J. A. (1984). Antibody against epididymal gly-
ability in protease treated zona-free mouse eggs occurs coinci-coprotein blocks fertilizing ability in rats. J. Reprod. Fertil. 72,
dent with recovery of a cell surface 94 kD protein. Mol. Reprod.467±471.
Dev. 33, 46±52.Deutzmann, R., Aumailley, M., Wiedemann, H., Pysny, W., Timpl,
KraÈtzschmar, J., Lum, L., and Blobel, C. P. (1996). Metargidin, aR., and Edgar, E. (1990). Cell adhesion, spreading and neurite
membrane-anchored metalloprotease-disintegrin protein with anstimulation by laminin fragment E8 depends on maintenance of
RGD integrin-binding sequence. J. Biol. Chem. 271, 4593±4596.secondary and tertiary structure in its rod and globular domain.
Eur. J. Biochem. 191, 513±522. Laemmli, U. K. (1970). Cleavage of structural proteins during the
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8611 / 6x27$$$165 06-18-97 02:36:00 dba
93Recombinant Fertilin b Binding to Mouse Eggs
assembly of the head of the bacteriophage T4. Nature 227, 680± subunits are functionally interchangeable. J. Cell Biol. 114, 1079±
1088.685.
Sonnenberg, A., Hogervorst, F., Osterop, A., and Veltman, F. E. M.Linder, B., Bammer, S., and Heinlein, U. A. O. (1995). Delayed
(1988a). Identi®cation and characterization of a novel antigentranslation and posttranslational processing of cyritestin, an inte-
complex on mouse mammary tumor cells using a monoclonalgral membrane protein of the mouse acrosome. Exp. Cell Res.
antibody against platelet glycoprotein Ic. J. Biol. Chem. 263,221, 66±72.
14030±14038.Loftus, J. C., Smith, J. W., and Ginsberg, M. H. (1994). Integrin me-
Sonnenberg, A., Modderman, P. W., and Hogervorst, F. (1988b).diated cell adhesion: The extracellular face. J. Biol. Chem. 269,
Laminin receptor on platelets is the integrin VLA-6. Nature 336,25235±25238.
487±489.Lopez, L. C., and Shur, B. D. (1987). Redistribution of mouse sperm
Sonnenberg, A., Linders, C. J. T., Modderman, P. W., Damsky,surface galactosyltransferase after the acrosome reaction. J. Cell.
C. H., Aumailley, M., and Timpl, R. (1990). Integrin recognitionBiol. 105, 1663±1670.
of different cell binding fragments of laminin (P1, E3, E8) andMortillo, S., and Wassarman, P. M. (1991). Differential binding of
evidence that a6b1 but not a6b4 functions as a major receptor forgold-labeled zona pellucida glycoproteins mZP2 and mZP3 to
fragment E8. J. Cell Biol. 110, 2145±2155.mouse sperm membrane compartments. Development 113, 141±
Takeichi, M. (1990). Cadherins: A molecular family important in149.
selective cell±cell adhesion. Annu. Rev. Biochem. 59, 237±252.Myles, D. G. (1993). Molecular mechanisms of sperm-egg mem-
Tarone, G., Russo, M. A., Hirsch, E., Odorisio, T., Altruda, F., Si-brane binding and fusion in mammals. Dev. Biol. 158, 35±45.
lengo, L., and Siracusa, G. (1993). Expression of b1 integrin com-Myles, D. G., Kimmel, L. H., Blobel, C. P., White, J. M., and Prima-
plexes on the surface of unfertilized mouse oocytes. Develop-koff, P. (1994). Identi®cation of a binding site in the disintegrin
ment 117, 1369±1375.domain of fertilin required for sperm-egg fusion. Proc. Natl.
Vidaeus, C. M., Von Kapp-Herr, C., Golden, W., Eddy, R. L., Shows,
Acad. Sci. USA 91, 4195±4198.
T. B., and Herr, J. C. (1997). Human fertilin b: Identi®cation,
Okabe, M., Yagasaki, M., Oda, H., Matzno, S., Kohama, Y., and characterization, and chromosonal mapping of an ADMA gene
Mimura, T. (1988). Effect of a monclonal anti-mouse sperm anti- family member. Mol. Rep. Dev. 46, 363±369.
body (OBF13) on the interaction of mouse sperm with zona-free Weskamp, G., KraÈtzschmar, J., Reid, M. S., and Blobel, C. P. (1996).
mouse and hamster eggs. J. Reprod. Immunol. 13, 211±219. MDC9, a widely expressed cellular disintegrin containing SH3
Okabe, M., Nagira, M., Kawai, Y., Matzno, S., Mimura, T., and ligand domains. J. Cell Biol. 132, 717±726.
Tanaka, K. (1990). A human sperm antigen possibly involved in Whitten, W. K. (1971). Nutrient requirements for the culture of
binding and/or fusion with zona-free hamster eggs. Fertil. Steril. preimplantation embryos in vitro. Adv. Bio. Sci. 6, 129±139.
54, 1121±1126. Wolfsberg, T. G., Bazan, J. F., Blobel, C. P., Myles, D. G., Primakoff,
Perry, A. C. F., Gichuhi, P. M., Jones, R., and Hall, L. (1995). Clon- P., and White, J. M. (1993). The precursor region of a protein
ing and analysis of monkey fertilin reveals novel a subunit iso- active in sperm-egg fusion contains metalloprotease domain and
forms. Biochem. J. 307, 843±850. a disintegrin domain: Structural, functional, and evolutionary
Primakoff, P., Hyatt, H., and Tredick-Kline, J. (1987). Identi®cation implications. Proc. Natl. Acad. Sci. USA 90, 10783±10787.
and puri®cation of a sperm surface protein with a potential role Wolfsberg, T. G., Primakoff, P., Myles, D. G., and White, J. M.
in sperm-egg membrane fusion. J. Cell Biol. 104, 141±149. (1995a). ADAM, a novel family of membrane proteins containing
Ramarao, C. S., Myles, D. G., White, J. M., and Primakoff, P. (1996). A Disintegrin And Metalloprotease Domain: Multipotential
Initial evaluation of fertilin as an immunocontraceptive antigen functions in cell±cell and cell±matrix interactions. J. Cell Biol.
and molecular cloning of the cynomolgus monkey fertilin b sub- 131, 275±278.
Wolfsberg, T. G., Straight, P. D., Gerena, R. L., Huovila, A.-P. J.,unit. Mol. Reprod. Dev. 43, 70±75.
Primakoff, P., Myles, D. G., and White, J. M. (1995b). ADAM, aRooke, J., Pan, D., Xu, T., and Rubin, G. M. (1996). KUZ, a con-
widely distributed and developmentally regulated gene familyserved metalloprotease-disintegrin protein with two roles in Dro-
encoding membrane proteins with A Disintegrin And Metallo-sophila neurogenesis. Science 273, 1227±1231.
protease domain. Dev. Biol. 169, 378±383.Saling, P. M., Irons, G., and Waibel, R. (1985). Mouse sperm anti-
Yagami-Hiromisu, T., Sato, T., Kurisaki, T., Kamijo, K., Nabes-gens that participates in fertilization: I. Inhibitions of sperm fu-
hima, Y., and Fujisawa-Sehara, A. (1995). A metalloprotease-dis-sion with the egg plasma membrane using monoclonal antibod-
integrin participating in myoblast fusion. Nature 377, 652±656.ies. Biol. Reprod. 33, 515±526.
Yanagimachi, R. (1994). Mammalian fertilization. In ``The Physiol-Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). ``Molecular
ogy of Reproduction'' (E. Knobil and J. D. Neill, Eds.), pp. 189±Cloning: A Laboratory Manual,'' 2nd ed. Cold Spring Harbor Lab-
317. Raven Press, New York.oratory Press, Cold Spring Harbor, NY.
Solowska, J., Edelman, J. M., Albelda, S. M., and Buck, C. A. (1991). Received for publication November 21, 1996
Accepted May 1, 1997Cytoplasmic and transmembrane domains of integrin b1 and b3
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8611 / 6x27$$$165 06-18-97 02:36:00 dba
